Skip to main content

Table 1 Patient characteristics

From: Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Parameter All patients (%) Patients with IR (%) Patients with AR (%)
Total 50 28 22
Sex
 Female 18 (36) 12 (43) 6 (27)
 Male 32 (64) 16 (57) 16 (73)
Stage
 I 1 (2) 0 1 (5)
 II 26 (52) 16 (57) 10 (45)
 III 7 (14) 2 (7) 5 (23)
 IV 16 (32) 10 (36) 6 (27)
TG/TL
 1 12 (24) 6 (21) 6 (27)
 2 17 (34) 10 (36) 7 (32)
 3 21 (42) 12 (43) 9 (41)
ESR ≥ 30 mm/h
 Yes 33 (66) 19 (68) 14 (64)
 No 17 (34) 9 (32) 8 (36)
Bulk ≥ 200 ml
 Yes 17 (34) 12 (43) 5 (23)
 No 33 (66) 16 (57) 17 (77)
B-symptoms
 Yes 23 (46) 12 (43) 11 (50)
 No 27 (54) 16 (57) 11 (50)
Extranodal
 Yes 8 (16) 4 (14) 4 (18)
 No 42 (84) 24 (86) 18 (82)
Protocol
 PHL-C1 42 (84) 25 (89) 17 (77)
 PHL-C2 8 (16) 3 (11) 5 (23)
  1. IR inadequate response, AR adequate response, TG/TL treatment group/level, ESR erythrocyte sedimentation rate